Published in Thorax on April 06, 2006
Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med (2008) 9.49
Reproducibility of QuantiFERON-TB gold in-tube assay. Clin Vaccine Immunol (2008) 1.86
Recent advances in the diagnosis of childhood tuberculosis. Arch Dis Child (2007) 1.65
A three-way comparison of tuberculin skin testing, QuantiFERON-TB gold and T-SPOT.TB in children. PLoS One (2008) 1.53
New diagnostic methods for tuberculosis. Curr Opin Infect Dis (2009) 1.40
Is IP-10 a better biomarker for active and latent tuberculosis in children than IFNgamma? PLoS One (2008) 1.32
Identifying predictors of interferon-γ release assay results in pediatric latent tuberculosis: a protective role of bacillus Calmette-Guerin?: a pTB-NET collaborative study. Am J Respir Crit Care Med (2012) 1.30
Comparison of two commercially available gamma interferon blood tests for immunodiagnosis of tuberculosis. Clin Vaccine Immunol (2007) 1.30
Factors associated with the performance of a blood-based interferon-γ release assay in diagnosing tuberculosis. PLoS One (2012) 1.04
Temporal dynamics of interferon gamma responses in children evaluated for tuberculosis. PLoS One (2009) 1.03
Whole blood interferon-gamma responses to mycobacterium tuberculosis antigens in young household contacts of persons with tuberculosis in Uganda. PLoS One (2008) 0.99
Performance of two commercial blood IFN-gamma release assays for the detection of Mycobacterium tuberculosis infection in patient candidates for anti-TNF-alpha treatment. Eur J Clin Microbiol Infect Dis (2008) 0.96
Evaluation of interferon-gamma release assays in the diagnosis of recent tuberculosis infection in health care workers. PLoS One (2009) 0.96
Reversion and conversion of Mycobacterium tuberculosis IFN-gamma ELISpot results during anti-tuberculous treatment in HIV-infected children. BMC Infect Dis (2010) 0.93
Detection of tuberculosis in HIV-infected children using an enzyme-linked immunospot assay. AIDS (2009) 0.93
Longitudinal analysis of QuantiFERON-TB Gold In-Tube in children with adult household tuberculosis contact in South Africa: a prospective cohort study. PLoS One (2011) 0.91
Diagnosing latent tuberculosis in high-risk individuals: rising to the challenge in high-burden areas. J Infect Dis (2011) 0.87
Analysis of latent tuberculosis and mycobacterium avium infection data using mixture models. BMC Public Health (2006) 0.85
Latent tuberculosis infection in children: diagnostic approaches. Eur J Clin Microbiol Infect Dis (2012) 0.84
Gamma interferon release assays for diagnosis of tuberculosis infection in immune-compromised children in a country in which the prevalence of tuberculosis is low. J Clin Microbiol (2009) 0.84
Comparing interferon-gamma release assays to tuberculin skin test in Thai children with tuberculosis exposure. PLoS One (2014) 0.83
Interferon gamma assay for detecting latent tuberculosis infection in rheumatoid arthritis patients during infliximab administration. Rheumatol Int (2007) 0.82
Interferon-gamma release assays in the detection of latent tuberculosis infection in patients with inflammatory arthritis scheduled for anti-tumour necrosis factor treatment. Clin Rheumatol (2012) 0.79
Latent TB infection diagnosis in population exposed to TB subjects in close and poor ventilated high TB endemic zone in India. PLoS One (2014) 0.78
Usefulness of interferon-γ release assay for the diagnosis of latent tuberculosis infection in young children. Korean J Pediatr (2016) 0.78
Mycobacterium tuberculosis pyomyositis in an infant. Ann Med Health Sci Res (2013) 0.78
Tuberculosis Infection in Early Childhood and the Association with HIV-exposure in HIV-uninfected Children in Rural Uganda. Pediatr Infect Dis J (2016) 0.77
The Use of Interferon Gamma Inducible Protein 10 as a Potential Biomarker in the Diagnosis of Latent Tuberculosis Infection in Uganda. PLoS One (2016) 0.77
Cough Aerosol Cultures of Mycobacterium tuberculosis: Insights on TST / IGRA Discordance and Transmission Dynamics. PLoS One (2015) 0.76
Study of the BCG Vaccine-Induced Cellular Immune Response in Schoolchildren in Antananarivo, Madagascar. PLoS One (2015) 0.75
Whole blood IFN-gamma assay for detecting TB in children. Thorax (2006) 0.75
Dynamic QuantiFERON Response in Psoriasis Patients Taking Long-Term Biologic Therapy. Dermatol Ther (Heidelb) (2013) 0.75
Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis (2004) 8.41
Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet (2003) 8.30
A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N Engl J Med (1996) 7.66
Specific immune-based diagnosis of tuberculosis. Lancet (2000) 6.81
Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep (2005) 6.45
Global tuberculosis incidence and mortality during 1990-2000. Bull World Health Organ (1994) 6.11
Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens. Am J Respir Crit Care Med (2004) 5.78
Clinical practice. Latent tuberculosis infection. N Engl J Med (2002) 5.64
Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Am J Respir Crit Care Med (2001) 5.06
Effect of BCG vaccination on risk of Mycobacterium tuberculosis infection in children with household tuberculosis contact: a prospective community-based study. Lancet (2005) 4.82
Routine hospital use of a new commercial whole blood interferon-gamma assay for the diagnosis of tuberculosis infection. Am J Respir Crit Care Med (2005) 4.06
A meta-analysis of the effect of Bacille Calmette Guérin vaccination on tuberculin skin test measurements. Thorax (2002) 3.65
Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cells. AIDS (2002) 3.47
Comparison of tuberculin skin test and new specific blood test in tuberculosis contacts. Am J Respir Crit Care Med (2004) 3.20
Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Lancet (2001) 3.15
Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study. Lancet (2004) 3.07
Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infection. Lancet Infect Dis (2003) 2.79
Diagnosis and treatment of tuberculosis in children. Lancet Infect Dis (2003) 2.77
T-cell cytokine responses in human infection with Mycobacterium tuberculosis. Infect Immun (1995) 2.57
Long-term risk of tuberculosis among foreign-born persons in the United States. JAMA (1997) 2.54
Tuberculosis contacts but not patients have higher gamma interferon responses to ESAT-6 than do community controls in The Gambia. Infect Immun (2001) 1.74
Guidelines for using the QuantiFERON-TB test for diagnosing latent Mycobacterium tuberculosis infection. Centers for Disease Control and Prevention. MMWR Recomm Rep (2003) 1.74
T cell-based tracking of multidrug resistant tuberculosis infection after brief exposure. Am J Respir Crit Care Med (2004) 1.70
Enzyme-linked immunospot assay responses to early secretory antigenic target 6, culture filtrate protein 10, and purified protein derivative among children with tuberculosis: implications for diagnosis and monitoring of therapy. Clin Infect Dis (2005) 1.69
Childhood tuberculosis: out of control? Curr Opin Pulm Med (2002) 1.54
Evolution and current use of the tuberculin test. Clin Infect Dis (2001) 1.34
Gamma interferon-based immunodiagnosis of tuberculosis: comparison between whole-blood and enzyme-linked immunospot methods. J Clin Microbiol (2004) 1.32
Interferon-gamma assays for tuberculosis: is anergy the Achilles' heel? Am J Respir Crit Care Med (2005) 1.20
Spotting latent infection: the path to better tuberculosis control. Thorax (2003) 1.08
Dissociated production of interleukin-2 and immune (gamma) interferon by phytohaemagglutinin stimulated lymphocytes in healthy infants. Clin Exp Immunol (1985) 1.06
Ontogeny of T-helper 1 and T-helper 2 cytokine production in childhood. Pediatr Allergy Immunol (2001) 0.98
Ontogeny of phytohemagglutinin-induced gamma interferon by leukocytes of healthy infants and children: evidence for decreased production in infants younger than 2 months of age. J Pediatr (1987) 0.95
Interpretation of the tuberculin skin test reaction by pediatric providers. Pediatr Infect Dis J (2002) 0.78
What do parents of wheezy children understand by "wheeze"? Arch Dis Child (2000) 3.24
Anti-TNF therapy inhibits fever in cerebral malaria. Q J Med (1993) 2.47
Temporomandibular joint arthroscopy. Aust Dent J (1999) 2.29
Potentially lethal bacterial infection associated with varicella zoster virus. BMJ (1996) 1.88
Airway function in infants newly diagnosed with cystic fibrosis. Lancet (2001) 1.72
Procalcitonin as a diagnostic marker of meningococcal disease in children presenting with fever and a rash. Arch Dis Child (2002) 1.69
Australian immunisation registers: established foundations and opportunities for improvement. Euro Surveill (2012) 1.51
Retracted Modelling subcortical bone in finite element analyses: A validation and sensitivity study in the macaque mandible. J Biomech (2010) 1.45
"On-the-spot" vaccination. Med J Aust (1997) 1.39
Rigid-body analysis of a lizard skull: modelling the skull of Uromastyx hardwickii. J Biomech (2008) 1.19
Kawasaki disease. BMJ (1997) 1.18
Severe Bordetella holmesii infection in a previously healthy adolescent confirmed by gene sequence analysis. Clin Infect Dis (2001) 1.16
Heterologous ("nonspecific") and sex-differential effects of vaccines: epidemiology, clinical trials, and emerging immunologic mechanisms. Clin Infect Dis (2013) 1.11
Randomized, controlled trial comparing once daily and three times daily gentamicin in children with urinary tract infections. Pediatr Infect Dis J (2001) 1.09
Determining the rate of varicella vaccine rash in children with moderate-severe eczema. J Paediatr Child Health (2005) 1.09
Combined finite element and multibody dynamics analysis of biting in a Uromastyx hardwickii lizard skull. J Anat (2008) 1.08
Maternal antibodies to rotavirus: could they interfere with live rotavirus vaccines in developing countries? Vaccine (2010) 1.05
Cytomegalovirus transmission from breast milk in premature babies: does it matter? Arch Dis Child Fetal Neonatal Ed (2002) 1.01
Biological profile of L-745,870, a selective antagonist with high affinity for the dopamine D4 receptor. J Pharmacol Exp Ther (1997) 0.99
Antibody persistence after serogroup C meningococcal conjugate immunization of United Kingdom primary-school children in 1999-2000 and response to a booster: a phase 4 clinical trial. Clin Infect Dis (2010) 0.96
Absence of interferon-gamma release assay conversion following tuberculin skin testing. Int J Tuberc Lung Dis (2011) 0.95
Aspergillus laryngotracheobronchial infection in a 6-year-old girl following bone marrow transplantation. Int J Pediatr Otorhinolaryngol (2001) 0.94
Lung function testing in infants with cystic fibrosis: lessons from the past and future directions. Pediatr Pulmonol (2001) 0.94
FOXO3 expression during colorectal cancer progression: biomarker potential reflects a tumour suppressor role. Br J Cancer (2013) 0.94
Antibiotics for whooping cough (pertussis). Cochrane Database Syst Rev (2005) 0.92
Tuberculous dactylitis--an easily missed diagnosis. Eur J Clin Microbiol Infect Dis (2011) 0.91
Discriminative stimulus properties of the putative dopamine D3 receptor agonist, (+)-PD 128907: role of presynaptic dopamine D2 autoreceptors. Neuropharmacology (1998) 0.90
Influenza in the neonatal intensive care unit. J Perinatol (2006) 0.88
Phase I trial of RV3-BB rotavirus vaccine: a human neonatal rotavirus vaccine. Vaccine (2013) 0.87
The diagnosis and management of Kawasaki disease. J Paediatr Child Health (2005) 0.86
MMR immunisation. True anaphylaxis to MMR vaccine is extremely rare. BMJ (2001) 0.86
Discordance between TSTs and IFN-gamma release assays: the role of NTM and the relevance of mycobacterial sensitins. Eur Respir J (2010) 0.85
Adipsia and hypernatraemia in a dog with focal hypothalamic granulomatous meningoencephalitis. Aust Vet J (1999) 0.84
Antibiotics for whooping cough (pertussis). Cochrane Database Syst Rev (2007) 0.83
Reliability and validity of four anger scales. J Pers Assess (1981) 0.82
Initial experience with a rapid access blackouts triage clinic. Clin Med (2011) 0.81
Successful treatment of foscarnet-resistant herpes simplex stomatitis with intravenous cidofovir in a child. Pediatr Infect Dis J (2001) 0.81
L-745,870, a subtype selective dopamine D4 receptor antagonist, does not exhibit a neuroleptic-like profile in rodent behavioral tests. J Pharmacol Exp Ther (1997) 0.80
Long-term persistence of immunity and B-cell memory following Haemophilus influenzae type B conjugate vaccination in early childhood and response to booster. Clin Infect Dis (2014) 0.80
The potential danger of a solely interferon-gamma release assay-based approach to testing for latent Mycobacterium tuberculosis infection in children. Thorax (2010) 0.80
Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome. Lancet (1994) 0.79
Effects of altered photoperiod or maternal melatonin administration on plasma prolactin concentrations in fetal lambs. J Endocrinol (1989) 0.78
Learned helplessness: not dependent upon cognitions, attributions, or other such phenomenal experiences. J Pers (1982) 0.77
Duration of antibiotics in children with osteomyelitis and septic arthritis. J Paediatr Child Health (2002) 0.77
Cephalosporin resistant urinary tract infections in young children. J Paediatr Child Health (2004) 0.76
Non-steroidal anti-inflammatory drugs may predispose to invasive group A streptococcal infections. Arch Dis Child (1996) 0.75
Cyclical vomiting and hypertension with dermatographism and histamine release. J R Soc Med (1991) 0.75
Outcome following haemodialysis catheter-related Staphylococcus aureus bacteraemia. J Hosp Infect (1999) 0.75
Musculoskeletal side-effects of varicella. Lancet (1997) 0.75
The challenge of chronicity. A view from the other side. Maine Nurse (1985) 0.75
Migration of nuclear shell gaps studied in the d(24Ne,pγ)25Ne reaction. Phys Rev Lett (2010) 0.75
Adults with cerebral malaria do not have sensory evoked responses typical of deep general anaesthesia. Trans R Soc Trop Med Hyg (2000) 0.75
Towards evidence based medicine for paediatricians. How effective is varicella-zoster immunoglobulin (VZIG) in preventing chickenpox in neonates following perinatal exposure? Arch Dis Child (2009) 0.75
Auditory- and somatosensory-evoked potentials in cerebral malaria and anaesthesia: a comparison. Eur J Anaesthesiol (2002) 0.75
CEP-1347 increases ChAT activity in culture and promotes cholinergic neurone survival following fimbria-fornix lesion. Neuroreport (2000) 0.75
Fever in a returned traveller. J Paediatr Child Health (2004) 0.75
Halo structure of (14)Be. Phys Rev Lett (2001) 0.75
Structure of 12Be: intruder d-wave strength at N=8. Phys Rev Lett (2006) 0.75
Alpha:2n:alpha molecular band in 10Be. Phys Rev Lett (2006) 0.75
ASO titer or not? When to use streptococcal serology: a guide for clinicians. Eur J Clin Microbiol Infect Dis (2015) 0.75
Emergency services: leather-clad lifesavers. Nurs Stand (1995) 0.75
Mycobacterium ulcerans infection diagnosed by polymerase chain reaction. J Paediatr Child Health (2002) 0.75